Showing results (551-560 of 689) with videos related to
Sort By:
Pageof 69
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2017
The patient buddy app can potentially prevent hepatic encephalopathy-related readmissionsDinesh Ganapathy, Chathur Acharya, Jatinder Lachar, et al.Journal of Hepatology|December 25, 2019
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.Hepatology (Baltimore, Md.)|July 22, 2010
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri, Jeanne M Clark, Nathan M Bass, et al.Alimentary Pharmacology & Therapeutics|March 18, 2022
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)Danielle Brandman, Marie Boyle, Stuart McPherson, et al.The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.Journal of Hepatology|June 5, 2016
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancerAmon Asgharpour, Sophie C Cazanave, Tommy Pacana, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2016
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational studyMasatoshi Kudo, Riccardo Lencioni, Jorge A Marrero, et al.The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.Metabolic Brain Disease|March 5, 2014
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axisVishwadeep Ahluwalia, James B Wade, Douglas M Heuman, et al.Pageof 69